Filing Flows › Upstream Bio (UPB) › How it makes money
How Upstream Bio (UPB) makes money
Upstream Bio (UPB) made $773K of revenue in the second quarter 2026 (Q2 2026), -18% from a year earlier.
Drawing the Sankey…
Where each dollar of revenue goes
| Line | Q2 2026 | % of revenue |
|---|---|---|
| Revenue | $773K | 100.0% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q2 2026 | $773K | -18% |
| Q1 2026 | $1.0M | +83% |
| Q4 2025 | $668K | +9% |
| Q3 2025 | $683K | +12% |
| Q2 2025 | $937K | +84% |
| Q1 2025 | $566K | -12% |
| Q4 2024 | $613K | +36% |
From Upstream Bio's 10-Q filed Aug 11, 2026 (on EDGAR).
Questions
How does Upstream Bio make money?
Upstream Bio (UPB) made $773K of revenue in the second quarter 2026 (Q2 2026), -18% from a year earlier.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.